免疫检查点阻断治疗曲霉病和毛霉病合并感染 - Suppr

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection.

作者信息

Banck Jan Christoph, Mueller Niklas, Mellinghoff Sibylle Christiane, Thelen Martin, Fraccaroli Alessia, Blumenberg Viktoria, Koehler Philipp, Kunz Wolfgang Gerhard, Rudelius Martina, Schrötzlmair Florian, Subklewe Marion, Schlößer Hans Anton, Tischer Johanna, Cornely Oliver Andreas, Lindner Lars Hartwin, von Bergwelt-Baildon Michael

机构信息

Department of Medicine III, University Hospital, LMU Munich, Germany.

Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Germany.

出版信息

Hemasphere. 2021 Feb 10;5(3):e530. doi: 10.1097/HS9.0000000000000530. eCollection 2021 Mar.

DOI:10.1097/HS9.0000000000000530

PMID:33604513

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7886469/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223d/7886469/3a168c8381aa/hs9-5-e530-g001.jpg

相似文献

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection.免疫检查点阻断治疗曲霉病和毛霉病合并感染

Hemasphere. 2021 Feb 10;5(3):e530. doi: 10.1097/HS9.0000000000000530. eCollection 2021 Mar.

[Coinfection of rhinocerebral mucormycosis and sinus aspergillosis].鼻脑型毛霉菌病与鼻窦曲霉菌病合并感染

Rev Peru Med Exp Salud Publica. 2015 Oct;32(4):813-7.

Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.口面部曲霉菌病和毛霉菌病合并症：复发性小儿胶质瘤的致命并发症——病例报告及文献综述

Mycopathologia. 2016 Oct;181(9-10):723-33. doi: 10.1007/s11046-016-0021-8. Epub 2016 Jun 27.

Pulmonary aspergillosis, mucormycosis, and actinomycosis co-infection presenting as a cavitary lesion in a patient with diabetes.肺曲霉病、毛霉病和放线菌病合并感染，表现为一名糖尿病患者的空洞性病变。

Chin Med J (Engl). 2019 Oct 20;132(20):2512-2513. doi: 10.1097/CM9.0000000000000468.

Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: A case report.一名糖尿病患者并发脑鼻眶毛霉菌病和曲霉菌病：病例报告

IDCases. 2020 Dec 9;23:e01022. doi: 10.1016/j.idcr.2020.e01022. eCollection 2021.

When you can't see the wood for the trees. Mucor circinelloides: A rare case of primary cutaneous zygomycosis.只见树木不见森林时。卷枝毛霉：原发性皮肤接合菌病的罕见病例。

J Mycol Med. 2015 Jun;25(2):151-4. doi: 10.1016/j.mycmed.2015.02.043. Epub 2015 Apr 1.

Comparison in Quantities from Including Angles Comprising Lines of Hypha Themselves in Histological Images between Mucorales and Aspergillus.毛霉目和曲霉在组织学图像中包含菌丝自身线条的角度的数量比较。

Med Mycol J. 2019;60(4):85-89. doi: 10.3314/mmj.19-00006.

Using immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis.运用免疫组织化学评估组织形态学诊断曲霉菌病和毛霉菌病的准确性。

Clin Infect Dis. 2015 Dec 1;61(11):1664-70. doi: 10.1093/cid/civ660. Epub 2015 Aug 3.

A comparison of histomorphologic diagnosis with culture- and immunohistochemistry-based diagnosis of invasive aspergillosis and mucormycosis.组织形态学诊断与基于培养和免疫组织化学的侵袭性曲霉菌病和毛霉菌病的比较。

Infect Dis (Lond). 2020 Apr;52(4):279-283. doi: 10.1080/23744235.2020.1716063. Epub 2020 Jan 23.

Diagnostic value of a semi-nested PCR for the diagnosis of mucormycosis and aspergillosis from paraffin-embedded tissue: A single center experience.半巢式聚合酶链反应对石蜡包埋组织中毛霉病和曲霉病诊断的价值：单中心经验

Pathol Res Pract. 2016 May;212(5):393-7. doi: 10.1016/j.prp.2016.02.010. Epub 2016 Feb 2.

引用本文的文献

Case Report: Immune checkpoint inhibitor exhibits dual benefits for a refractory lymphoma patient with disseminated mucormycosis.病例报告：免疫检查点抑制剂对一名患有播散性毛霉菌病的难治性淋巴瘤患者显示出双重益处。

Front Med (Lausanne). 2025 Jul 2;12:1608828. doi: 10.3389/fmed.2025.1608828. eCollection 2025.

Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment Option.侵袭性霉菌感染患者的免疫表型支持将PD-1抑制作为潜在治疗选择。

Mycoses. 2025 Mar;68(3):e70044. doi: 10.1111/myc.70044.

Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies.抗真菌免疫：模式识别受体识别、适应性反应及基于免疫的治疗进展

Sci China Life Sci. 2025 Mar 5. doi: 10.1007/s11427-024-2835-y.

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.新型抗真菌药物和治疗方法，以应对耐药性并改善侵袭性真菌感染的治疗结局。

Clin Microbiol Rev. 2024 Jun 13;37(2):e0007423. doi: 10.1128/cmr.00074-23. Epub 2024 Apr 11.

New anticancer therapeutics impact fungal pathobiology, infection dynamics, and outcome.新型抗癌疗法会影响真菌病理生物学、感染动态及治疗结果。

PLoS Pathog. 2023 Dec 21;19(12):e1011845. doi: 10.1371/journal.ppat.1011845. eCollection 2023 Dec.

Prediction of pulmonary aspergillosis in patients with ventilator-associated pneumonia.机械通气相关性肺炎患者肺曲霉病的预测

Ann Intensive Care. 2023 Nov 7;13(1):109. doi: 10.1186/s13613-023-01199-6.

Unmasking a fungal fire.揭开真菌火灾的神秘面纱。

PLoS Pathog. 2023 May 18;19(5):e1011355. doi: 10.1371/journal.ppat.1011355. eCollection 2023 May.

What Is New in Pulmonary Mucormycosis?肺毛霉病有哪些新进展？

J Fungi (Basel). 2023 Feb 28;9(3):307. doi: 10.3390/jof9030307.

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions.检查点抑制剂作为抗真菌免疫疗法：前景、挑战和未解决的问题。

Front Immunol. 2022 Oct 25;13:1018202. doi: 10.3389/fimmu.2022.1018202. eCollection 2022.

Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis.病例报告：免疫检查点抑制剂联合γ干扰素附加抗真菌治疗难治性新冠相关肺曲霉病和脑毛霉病。

Front Immunol. 2022 Jun 1;13:900522. doi: 10.3389/fimmu.2022.900522. eCollection 2022.

本文引用的文献

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南：欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。

Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.

Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets.免疫检查点抑制剂在急性髓系白血病中的应用：新型联合疗法与治疗靶点

Curr Oncol Rep. 2019 Mar 23;21(4):37. doi: 10.1007/s11912-019-0781-7.

BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways.BRAF和MEK抑制剂通过调节TCR和AKT信号通路，对纳武单抗诱导的T细胞活化产生不同影响。

Oncoimmunology. 2018 Oct 29;8(1):e1512456. doi: 10.1080/2162402X.2018.1512456. eCollection 2019.

A novel approach to candidemia? The potential role of checkpoint inhibition.一种新方法治疗念珠菌血症？检查点抑制的潜在作用。

Med Mycol. 2019 Feb 1;57(2):151-154. doi: 10.1093/mmy/myy089.

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.评估接受抗 PD-1 免疫治疗患者体内表达 PD-1 的 T 细胞的精确数量。

Cancer Immunol Immunother. 2018 Dec;67(12):1845-1851. doi: 10.1007/s00262-018-2244-7. Epub 2018 Sep 14.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗：2017 年 ESCMID-ECMM-ERS 指南执行摘要。

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

Anti-PD-1 Antibody Treatment Promotes Clearance of Persistent Cryptococcal Lung Infection in Mice.抗程序性死亡蛋白1（PD-1）抗体治疗促进小鼠持续性肺隐球菌感染的清除。

J Immunol. 2017 Nov 15;199(10):3535-3546. doi: 10.4049/jimmunol.1700840. Epub 2017 Oct 16.

Nivolumab plus interferon-γ in the treatment of intractable mucormycosis.纳武单抗联合γ干扰素治疗难治性毛霉病

Lancet Infect Dis. 2017 Jan;17(1):18. doi: 10.1016/S1473-3099(16)30541-2.

Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway.程序性死亡蛋白1（PD-1）检查点通路的分子与生化方面

N Engl J Med. 2016 Nov 3;375(18):1767-1778. doi: 10.1056/NEJMra1514296.

T cells from patients with Candida sepsis display a suppressive immunophenotype.念珠菌败血症患者的T细胞表现出抑制性免疫表型。

Crit Care. 2016 Jan 20;20:15. doi: 10.1186/s13054-016-1182-z.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献